SOAT1
Sterol O-acyltransferase 1
Also known as: ACAT, ACAT1, SOAT, SOAT1_HUMAN, STAT
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P35610
- Gene
- SOAT1
- Ensembl
- ENSG00000057252
- Chromosome
- 1
- Canonical length
- 550 aa
- Protein class
- Enzymes, FDA approved drug targets, Metabolic proteins, Predicted membrane proteins
- Subcellular location
- Endoplasmic reticulum
- Quaternary structure
- Homotetramer
OverviewNCBI Gene
The protein encoded by this gene belongs to the acyltransferase family. It is located in the endoplasmic reticulum, and catalyzes the formation of fatty acid-cholesterol esters. This gene has been implicated in the formation of beta-amyloid and atherosclerotic plaques by controlling the equilibrium between free cholesterol and cytoplasmic cholesteryl esters. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Nov 2011]
Canonical amino-acid sequenceUniProt
550 residues, UniProt reviewed canonical sequence.
>P35610|SOAT1
1 MVGEEKMSLR NRLSKSRENP EEDEDQRNPA KESLETPSNG RIDIKQLIAK KIKLTAEAEE
61 LKPFFMKEVG SHFDDFVTNL IEKSASLDNG GCALTTFSVL EGEKNNHRAK DLRAPPEQGK
121 IFIARRSLLD ELLEVDHIRT IYHMFIALLI LFILSTLVVD YIDEGRLVLE FSLLSYAFGK
181 FPTVVWTWWI MFLSTFSVPY FLFQHWATGY SKSSHPLIRS LFHGFLFMIF QIGVLGFGPT
241 YVVLAYTLPP ASRFIIIFEQ IRFVMKAHSF VRENVPRVLN SAKEKSSTVP IPTVNQYLYF
301 LFAPTLIYRD SYPRNPTVRW GYVAMKFAQV FGCFFYVYYI FERLCAPLFR NIKQEPFSAR
361 VLVLCVFNSI LPGVLILFLT FFAFLHCWLN AFAEMLRFGD RMFYKDWWNS TSYSNYYRTW
421 NVVVHDWLYY YAYKDFLWFF SKRFKSAAML AVFAVSAVVH EYALAVCLSF FYPVLFVLFM
481 FFGMAFNFIV NDSRKKPIWN VLMWTSLFLG NGVLLCFYSQ EWYARQHCPL KNPTFLDYVR
541 PRSWTCRYVFLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SOAT1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 9
- Mean surface accessibility (rSASA)
- 0.35
- Highest tissue expression
- 156 nTPM
Expression across tissuesHPA
Tissue
- adrenal gland: 156 nTPM
- salivary gland: 37 nTPM
- prostate: 26 nTPM
- pancreas: 25 nTPM
- lung: 20 nTPM
- gallbladder: 19 nTPM
Single-cell type
- adrenal cortex cells: 898 nCPM
- salivary acinar cells: 244 nCPM
- monocytes: 224 nCPM
- prostatic glandular cells: 193 nCPM
- macrophages: 183 nCPM
- endometrial glandular cells: 178 nCPM
Immune cell
- basophil: 56 nTPM
- classical monocyte: 54 nTPM
- myeloid DC: 49 nTPM
- neutrophil: 40 nTPM
- NK-cell: 38 nTPM
- intermediate monocyte: 34 nTPM
Brain region
- white matter: 33 nTPM
- medulla oblongata: 27 nTPM
- choroid plexus: 25 nTPM
- spinal cord: 23 nTPM
- pons: 21 nTPM
- thalamus: 21 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.95
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.98
- DepMap mean gene effect
- 0.03
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cholesterol efflux
- cholesterol homeostasis
- cholesterol metabolic process
- cholesterol storage
- low-density lipoprotein particle clearance
- macrophage derived foam cell differentiation
- positive regulation of amyloid precursor protein biosynthetic process
- very-low-density lipoprotein particle assembly
Molecular functions
- cholesterol binding
- cholesterol O-acyltransferase activity
- fatty-acyl-CoA binding
- identical protein binding
- sterol O-acyltransferase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of SOAT1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SOAT1 as an antibody target. Whether an autoantibody or antibody against SOAT1 could matter depends on whether native SOAT1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SOAT1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label SOAT1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...